Extended Data Fig. 9: BLI traces from epitope mapping of anti-SARS-CoV-2 RBD antibodies.
From: Anti-SARS-CoV-2 receptor-binding domain antibody evolution after mRNA vaccination
a, b, BLI traces from competition experiments used to determine epitope targets of anti-SARS-CoV-2 RBD antibodies isolated from vaccinees at 1.3m (a) or 5m (b) post-boost, as illustrated in Extended Data Fig. 8.
